Kinematic analysis of kinases and their oncogenic mutations - Kinases and their mutation kinematic analysis

Xiyu Chen1, Sigrid Leyendecker1

  • 1Institute of Applied Dynamics, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91058, Erlangen, Germany.

PubMed

Insights

Protein kinases regulate cellular activity, but their dysfunction causes cancer. Kinematic Flexibility Analysis reveals the activation loop stabilizes active kinase conformations, impacting drug development.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Computational Biology

Background:

  • Protein kinases are enzymes regulating cellular functions via phosphorylation.
  • Dysregulated kinase activity is linked to oncogenesis.
  • Understanding kinase conformational dynamics is vital for drug discovery.

Purpose of the Study:

  • To analyze kinase flexibility and conformational states using Kinematic Flexibility Analysis (KFA).
  • To investigate the role of the activation loop in kinase structure and function.
  • To examine the impact of specific mutations on kinase flexibility.

Main Methods:

  • Structural analysis of 79 PDB crystal structures based on similarity to 5UG9.
  • Classification of structures into 5 clusters based on DFG motif phenylalanine position.
  • Application of KFA to assess macromolecular flexibility and conformational changes.
  • Analysis of hydrogen bond patterns and secondary structures (α-helices).

Main Results:

  • The kinase activation loop acts as a 'lock', stabilizing active conformations by rigidifying adjacent α-helices.
  • The L858R mutation associated with non-small cell lung cancer increases active-state kinase flexibility.
  • Active-state kinases show a higher prevalence of α-helices compared to inactive states.

Conclusions:

  • KFA provides insights into kinase conformational dynamics and flexibility.
  • The activation loop's role in stabilizing active kinase conformations is elucidated.
  • Findings are relevant for understanding kinase mutations and developing targeted therapies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K